Stay ahead with the latest from NHTA Insights and updates shaping the future of Market Access, Nordic RWE, and Policy.
Insights
Norway adopts seven new treatments across cancer and trauma care
Norway’s Decision Forum recommended seven of nine cases at its 19 October meeting. Among the treatments recommended for introduction: Polatuzumab vedotin (Polivy) with rituximab, cyclophosphamide,…
Read more CHMP issues six positive opinions in October
EMA’s CHMP issued six positive opinions at its October 2026 meeting. The recommendations covered: Rasonque (daraxonrasib) for previously treated metastatic pancreatic adenocarcinoma, following a phased…
Read more 
